Menlo Ventures Management, L.P.
Menlo Ventures Management, L.P. reported 3 US-listed holdings worth $357.4 million in its 13F for the quarter ended 30 June 2026, filed 10 August 2026. Its largest: Chime Finl Inc (100.0%), Braze Inc. (0.0%) and Senti Biosciences Holdings (0.0%). Against the quarter before, it opened 1 position, added to 0, trimmed 1 and sold out of 1.
Reported holdings$357.4M+9.3% on Q1 2026
Positions3as many as Q1 2026
The largest ten100.0%of its reported holdings
Latest 13FQ2 2026filed 10 August 2026
OpenedHeldTrimmed
The 3 largest of its 3 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What it did on the quarter
Opened 1Held 1Trimmed 1Sold out 1
Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held
Opened 1
- Senti Biosciences Holdings SNTI$39,311
Trimmed 1
- Braze Inc. BRZE-965 shares · -17%
Sold out of 1
- Senti Biosciences Inc. SNTI$29,018 last quarter
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Chime Finl Inc CHYM | 17.4M | $357.2 million | 99.96% | no change |
| Braze Inc. BRZE | 4.6K | $100,078 | 0.03% | -965 |
| Senti Biosciences Holdings SNTI | 35.7K | $39,311 | 0.01% | new |
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.